ArticleBMC pediatrics2025
Association of IGF-1 with hypertension among children and adolescents.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHypertension among children and adolescents is an escalating global health issue, significantly linked to cardiovascular risks and long-term complications in adulthood. Insulin-like growth factor 1 (IGF-1) is recognized for its role in growth and metabolism, yet its relationship with pediatric hypertension remains poorly understood. This study aimed to explore the association between IGF-1 levels and hypertension in children and adolescents.
methodsParticipants were categorized into Normal and Hypertension groups based on hypertension criteria. Demographic, anthropometric, and laboratory data were collected via medical records. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
resultsData from 586 participants were analyzed. The prevalence of hypertension was 22.3% among the participants. Lower IGF-1 levels were significantly associated with an increased risk of hypertension. Compared to the highest quartile of IGF-1, the adjusted odds ratios (OR) for hypertension were 6.99 for quartiles 1 (p < 0.05). The association was more pronounced in females, children aged 6-12 years, and those with abdominal obesity.
conclusionsLower IGF-1 levels are significantly associated with an increased risk of hypertension in children and adolescents. This association is evident across different subgroups, including sex, age, and obesity status. These findings highlight Maintaining the balance of these factors is critical for hypertension health, especially during adolescence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.